References
- Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.
- Zou ZY, Liu MS, Li XG, Cui LY. The distinctive genetic architecture of ALS in mainland China. J Neurol Neurosurg Psychiatry. 2015
- Aoki M, Ogasawara M, Matsubara Y, Narisawa K, Nakamura S, Itoyama Y, et al. Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: a possible new subtype of familial ALS. J Neurol Sci. 1994;126:77–83.
- Abe K, Aoki M, Ikeda M, Watanabe M, Hirai S, Itoyama Y. Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations. J Neurol Sci. 1996;136:108–16.
- Arisato T, Okubo R, Arata H, Abe K, Fukada K, Sakoda S, et al. Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families. Acta Neuropathol. 2003;106:561–8.
- Ohi T, Nabeshima K, Kato S, Yazawa S, Takechi S. Familial amyotrophic lateral sclerosis with His46Arg mutation in Cu/Zn superoxide dismutase presenting characteristic clinical features and Lewy body-like hyaline inclusions. J Neurol Sci. 2004;225:19–25.
- Ohi T, Saita K, Takechi S, Nabesima K, Tashiro H, Shiomi K, et al. Clinical features and neuropathological findings of familial amyotrophic lateral sclerosis with a His46Arg mutation in Cu/Zn superoxide dismutase. J Neurol Sci. 2002;197:73–8.
- Yamashita S, Kimura E, Yamamoto F, Migita A, Kanda E, Mita S, et al. Flexor-dominant myopathic phenotype in patients with His46Arg substitution in the Cu/Zn superoxide dismutase gene. J Neurol Sci. 2009;281:6–10.
- Holmoy T, Bjorgo K, Roos PM. Slowly progressing amyotrophic lateral sclerosis caused by H46R SOD1 mutation. Eur Neurol. 2007;58:57–8.
- Li X, Zhang L, Xie M, Liu M, Li B, Zhao H, et al. Screening of mutations in superoxide dismutate 1 gene in Chinese with familial amyotrophic lateral sclerosis. Zhonghua Shen Jing Ke Za Zhi. 2010;43:686–91.
- Zhang H, Tang L, Zhang N, Fan D. Association between superoxide dismutase 1 mutations and clinical phenotypes in Chinese patients with familial amyotrophic lateral sclerosis. Zhonghua Shen Jing Ke Za Zhi. 2012;45:453–8.
- Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu/Zn superoxide dismutase. Neurology. 1997;48:55–7.
- Camu W, Khoris J, Moulard B, Salachas F, Briolotti V, Rouleau GA, et al. Genetics of familial ALS and consequences for diagnosis. French ALS Research Group. J Neurol Sci. 1999;165 S21–6.
- Niemann S, Joos H, Meyer T, Vielhaber S, Reuner U, Gleichmann M, et al. Familial ALS in Germany: origin of the R115G SOD1 mutation by a founder effect. J Neurol Neurosurg Psychiatry. 2004;75:1186–8.
- Rabe M, Felbecker A, Waibel S, Steinbach P, Winter P, Muller U, et al. The epidemiology of Cu/Zn-SOD mutations in Germany: a study of 217 families. J Neurol. 2010;257:1298–302.
- Ostern R, Fagerheim T, Orstavik K, Holmoy T, Heiberg A, Lund-Petersen I, et al. Hereditary motor neuron disease in a large Norwegian family with a 'H46R' substitution in the superoxide dismutase 1 gene. Neuromuscul Disord. 2012;22:511–21.
- Holmoy T, Braaten O, Hovden IA, Tallaksen CM. A young woman with a weakening leg. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke. 2011;131:583–6.
- Hoyer H, Braathen GJ, Busk OL, Holla OL, Svendsen M, Hilmarsen HT, et al. Genetic diagnosis of Charcot-Marie-Tooth disease in a population by next-generation sequencing. BioMed Res Int. 2014;2014:210401.